Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov 4:8:320.
doi: 10.1186/1471-2407-8-320.

Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression

Affiliations

Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression

Nektaria Simiantonaki et al. BMC Cancer. .

Abstract

Background: Hypoxia-inducible factor 1 alpha (HIF-1alpha) is involved in processes promoting carcinogenesis of many tumors. However, its role in the development of colorectal cancer is unknown. To investigate the significance of HIF-1alpha during colorectal carcinogenesis and progression we examined its expression in precursor lesions constituting the conventional and serrated pathways, as well as in non-metastatic and metastatic adenocarcinomas.

Methods: Immunohistochemistry and Western blot is used to analyse HIF-1alpha expression in normal colonic mucosa, hyperplastic polyps (HPP), sessile serrated adenomas (SSA), low-grade (TA-LGD) and high-grade (TA-HGD) traditional adenomas as well as in non-metastatic and metastatic colorectal adenocarcinomas. Eight colorectal carcinoma cell lines are tested for their HIF-1alpha inducibility after lipopolysaccharide (LPS) stimulation using western blot and immunocytochemistry.

Results: In normal mucosa, HPP and TA-LGD HIF-1alpha was not expressed. In contast, perinuclear protein accumulation and nuclear expression of HIF-1alpha were shown in half of the examined SSA and TA-HGD. In all investigated colorectal carcinomas a significant nuclear HIF-1alpha overexpression compared to the premalignant lesions was observed but a significant correlation with the metastatic status was not found. Nuclear HIF-1alpha expression was strongly accumulated in perinecrotic regions. In these cases HIF-1alpha activation was seen in viable cohesive tumor epithelia surrounding necrosis and in dissociated tumor cells, which subsequently die. Enhanced distribution of HIF-1alpha was also seen in periinflammatory regions. In additional in vitro studies, treatment of diverse colorectal carcinoma cell lines with the potent pro-inflammatory factor lipopolysaccharide (LPS) led to HIF-1alpha expression and nuclear translocation.

Conclusion: We conclude that HIF-1alpha expression occurs in early stages of colorectal carcinogenesis and achieves a maximum in the invasive stage independent of the metastatic status. Perinecrotic activation of HIF-1alpha in invasive tumors underlines a dual role of HIF-1alpha by regulating both pro-survival and pro-death processes. HIF-1alpha up-regulation in response to LPS-mediated stimulation and periinflammatory expression in invasive carcinomas suggest its involvement in inflammatory events. These patterns of HIF-1alpha inducibility could contribute indirectly to the acquisition of a metastatic phenotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HIF-1α expression in precursor lesions of colorectal carcinogenesis. In normal mucosa (A), HP (B) and TA-LGD (C) specific HIF-1α expression was not seen. SSA and TA-HGD showed a strong diffusely perinuclear (D1 and E1) and on the surface crypts focally nuclear (D2 and E2) HIF-1α immunopositivity.
Figure 2
Figure 2
Detection of HIF-1α in human non-metastatic (A) and metastatic (B) primary colorectal carcinomas by Western blot. Staining with anti-β-actin (bottom blots respectively) was performed as control for loading. (N: corresponding normal epithelium; T: tumor epithelium).
Figure 3
Figure 3
Cytosolic (A-C) and nuclear (D and E) HIF-1α expression profiles detected in colorectal carcinomas. With respect to the cytoplasmic expression intensity weak (A), moderate (B) and strong (C) immunoreactivity was detected. With respect to the nuclear expression intensity weak (D) and strong (E) immunoreactivity was seen.
Figure 4
Figure 4
Accumulation of nuclear HIF-1α in perinecrotic (A1,2) and periinflammatory (B1,2 and C1,2) regions of the tumor tissue. In perinecrotic areas HIF-1α activation was seen in cohesive tumor epithelia surrounding necrosis and in dissociated, dying tumor cells. In periiflammatory areas tumoral HIF-1α activation was seen in the superficial tumor ulceration (B1,2) and in severe inflammation along the infiltrative pathway (C1,2). Magnification: 1 = 200×, 2 = 400×
Figure 5
Figure 5
Detection of HIF-1α in unstimulated and LPS-stimulated human colorectal carcinoma cell lines by Western blot. Staining with anti-β-actin was performed as control for loading.
Figure 6
Figure 6
Positive cytoplasmic and nuclear expression of HIF-1α in LPS-stimulated SW620 (A2) and HRT-18 (B2) colon carcinoma cell lines compared to native conditions (A1 and B1).
Figure 7
Figure 7
Schematic illustration of the HIF1α-mediated pathway in colorectal carcinogenesis and tumor progression.

Similar articles

Cited by

References

    1. Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47. doi: 10.1038/nrc704. - DOI - PubMed
    1. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9:10–17. doi: 10.1634/theoncologist.9-90005-10. - DOI - PubMed
    1. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–732. doi: 10.1038/nrc1187. - DOI - PubMed
    1. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830–5835. - PubMed
    1. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157:411–421. - PMC - PubMed

Publication types

MeSH terms

Substances